$60.91 -4.08 (%) AMAG Pharmaceuticals Inc - NASDAQ

Sep. 3, 2015 | 04:00 PM

Partner Headlines

  1. Why Biotech AMAG Pharma Is Worth $80 Now

    Benzinga | Aug. 18, 2015 | 10:23AM EST
  2. Benzinga's M&A Chatter for Monday June 29, 2015

    Benzinga | Jun. 29, 2015 | 19:43PM EST
  3. AMAG Pharma

    IBD | Jun. 29, 2015 | 18:45PM EST
  4. AMAG Pharma Acquiring Stem-Cell Bank For $700 Million

    IBD | Jun. 29, 2015 | 13:07PM EST
  5. Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Highest Operating Margin

    Benzinga | Jun. 23, 2015 | 05:01AM EST
  6. Top Performing Industries For June 18, 2015

    Benzinga | Jun. 18, 2015 | 10:30AM EST
  7. Benzinga's Top Initiations

    Benzinga | Jun. 12, 2015 | 09:19AM EST
  8. Deutsche Bank Initiates AMAG Pharmaceuticals With Hold

    Benzinga | Jun. 12, 2015 | 08:21AM EST
  9. 5 NASDAQ Healthcare Stocks With The Highest Profit Margin

    Benzinga | Jun. 10, 2015 | 09:21AM EST
  10. Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest ROI

    Benzinga | May. 13, 2015 | 04:45AM EST
  11. Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest ROA

    Benzinga | May. 5, 2015 | 04:51AM EST
  12. 5 Biotech Earnings Under The Microscope This Week

    Benzinga | Apr. 20, 2015 | 11:18AM EST
  13. Benzinga's Volume Movers

    Benzinga | Feb. 26, 2015 | 10:24AM EST
  14. Earnings Scheduled For February 9, 2015

    Benzinga | Feb. 9, 2015 | 04:58AM EST
  15. The 5 Biggest Biotech Stocks

    Benzinga | Jan. 20, 2015 | 16:43PM EST
  16. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 3

    Benzinga | Jan. 13, 2015 | 10:58AM EST
  17. Big Short Interest On These 5 Biotech Stocks

    Benzinga | Jan. 12, 2015 | 15:36PM EST
  18. AMAG Pharmaceuticals And Takeda Announce Mutual Termination of Agreement to License, Develop and Commercialize Ferumoxytol in Ex-U.S. Territories, Including Europe

    Benzinga | Dec. 29, 2014 | 08:02AM EST
  19. Meet 5 Top Drug Stocks That Are Bolting Past Market

    IBD | Dec. 2, 2014 | 08:02AM EST
  20. Events for the Week of Nov. 17-21, 2014

    Benzinga | Nov. 17, 2014 | 13:13PM EST
  21. GoPro Among Top 6 Stocks Outperforming The Market

    IBD | Oct. 7, 2014 | 08:02AM EST
  22. Benzinga's Top Upgrades

    Benzinga | Sep. 30, 2014 | 08:39AM EST
  23. FBR Capital Upgrades AMAG Pharmaceuticals To Outperform

    Benzinga | Sep. 30, 2014 | 08:19AM EST
  24. Benzinga's Volume Movers

    Benzinga | Sep. 29, 2014 | 10:17AM EST
  25. Morning Market Movers

    Benzinga | Sep. 29, 2014 | 09:36AM EST
  26. US Stock Futures Down Ahead Of Economic Data

    Benzinga | Sep. 29, 2014 | 07:37AM EST
  27. AMAG Pharma Announces Publication of Data from Trial of MuGard in the Journal Cancer

    Benzinga | Apr. 28, 2014 | 08:15AM EST
  28. Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Lowest PEG Ratio

    Benzinga | Feb. 13, 2014 | 04:18AM EST
  29. Benzinga's Top #PreMarket Losers

    Benzinga | Jan. 22, 2014 | 08:26AM EST
  30. US Stock Futures Down Ahead Of Earnings

    Benzinga | Jan. 22, 2014 | 07:15AM EST
  31. UPDATE: AMAG Pharmaceuticals Receives CRL from FDA for Supplemental NDA for Feraheme for Broader IDA Indication

    Benzinga | Jan. 22, 2014 | 06:57AM EST
  32. Earnings Scheduled For January 15, 2014

    Benzinga | Jan. 15, 2014 | 04:18AM EST
  33. Market Wrap For December 31: Markets End The Year On A Positive Note

    Benzinga | Dec. 31, 2013 | 16:29PM EST
  34. AMAG Pharmaceuticals Update Announces Preliminary 2012 Financial Results and 2013 Financial Guidance

    Benzinga | Jan. 6, 2013 | 05:34AM EST
  35. AMAG Pharmaceuticals, Inc. (AMAG) EVP, COO Frank E Thomas sells 10,000 Shares

    GuruFocus | Jan. 4, 2013 | 11:08AM EST
  36. AMAG Pharma Submits Supplemental NDA for Feraheme

    Benzinga | Dec. 24, 2012 | 01:32AM EST
  37. AMAG Pharma Reports New Data from Ferumoxytol Pivotal Phase III Broad Iron Deficiency Anemia Program

    Benzinga | Dec. 10, 2012 | 04:17AM EST
  38. AMAG Pharmaceuticals Inc. (AMAG) EVP, COO Frank E Thomas sells 5,000 Shares

    GuruFocus | Dec. 4, 2012 | 10:56AM EST
  39. AMAG Pharmaceuticals Inc. (AMAG) EVP, COO Frank E Thomas sells 5,000 Shares

    GuruFocus | Dec. 4, 2012 | 08:33AM EST
  40. AMAG Pharmaceuticals, Inc. (AMAG) EVP, COO Frank E Thomas sells 5,000 Shares

    GuruFocus | Dec. 4, 2012 | 01:36AM EST
  41. Rienso Receives Swiss Marketing Authorization for the Treatment of Iron Deficiency Anemia in Adult Patients with Chronic Kidney Disease

    Benzinga | Sep. 5, 2012 | 02:17AM EST
  42. AMAG Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus | Aug. 7, 2012 | 10:23AM EST
  43. Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Highest Cash

    Benzinga | Aug. 1, 2012 | 19:05PM EST
  44. Financial Breakfast: Morning News Summary for July 18, 2012

    Benzinga | Jul. 18, 2012 | 01:20AM EST
  45. AMAG Pharmaceuticals Announces Positive Preliminary Results from its Phase III Study Evaluating Feraheme Compared to Placebo in Patients with Iron Deficiency Anemia

    Benzinga | Jul. 18, 2012 | 00:48AM EST
  46. Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Highest Cash

    Benzinga | Jul. 12, 2012 | 20:47PM EST
  47. AMAG Pharmaceuticals Realigns Operating Cost Structure; Expects to Reduce Workforce by 45 Position by the end of 2012

    Benzinga | Jun. 25, 2012 | 10:31AM EST
  48. UPDATE: Ladenburg Thalmann Upgrades AMAG Pharmaceuticals to Buy

    Benzinga | May. 17, 2012 | 04:44AM EST
  49. Benzinga's Top Downgrades With Color for May 10, 2012

    Benzinga | May. 10, 2012 | 05:54AM EST
  50. UPDATE: Ladenburg Thalmann Downgrades AMAG Pharmaceuticals; Removes PT

    Benzinga | May. 10, 2012 | 04:24AM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!